Prior to admission, her diabetes treatment consisted of linagliptin (5 mg/day), mitiglinide (20 mg/day), and 4 units of insulin degludec/insulin aspart (IDeg/Asp) injections in the morning. This evidence concerns the gene INS and diabetes mellitus.